<DOC>
	<DOCNO>NCT00896675</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood laboratory may help doctor learn cancer . It may also help doctor predict well patient respond treatment . PURPOSE : This research study look protein blood sample predict treatment benefit patient recurrent and/or metastatic squamous cell head neck cancer .</brief_summary>
	<brief_title>Blood Proteins Predicting Treatment Benefit Patients With Recurrent and/or Metastatic Head Neck Squamous Cell Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To identify head neck squamous cell cancer patient benefit treatment EGFR inhibitor ( i.e. , erlotinib hydrochloride , gefitinib , cetuximab ) VEGF inhibitor ( i.e. , bevacizumab ) , base predictive proteomic profile patient blood sample . OUTLINE : This multicenter study . Blood sample analyze proteomic profile determine good bad prognosis patient treat without EGFR inhibitor and/or VEGF inhibitor .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis squamous cell head neck cancer Recurrent and/or metastatic disease Meets 1 follow criterion : Previously treat EGFR inhibitor and/or VEGF inhibitor 1 follow clinical trial , available blood sample : A Phase I/II Study Bevacizumab ( rhu MAb VEGF ) Combination With OSI774 Patients With Recurrent Metastatic Cancer Head Neck A Phase II Study 250mg ZD1839 Monotherapy Recurrent Metastatic Both Recurrent Metastatic Squamous Cell Carcinoma Head Neck Previously treat cetuximab blood sample available protocol VUVICCHN0356 Previously treat conventional chemotherapy blood sample available protocol VUVICCHN0356 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
</DOC>